Saturday 17 October 2026 Export PBYI’s income statement to Excel — free account

Puma Biotechnology, Inc.

Puma Biotechnology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $228.4 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 7.75%, EPS grew 33.3%, free cash flow fell 88.5% and total debt fell 79.8%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

9.83 0.69 −6.56%

Follow PBYI

Alert me

Market cap: $543.0M
P/E: 18.2×
Fwd P/E: 24.2×
Dividend yield: —
F-score: 8/9
Altman Z: −4.16
Beneish M: −2.06
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	7	7	8	7	+8 more TTM periods Free account
ROE Full definition →	21.97%	21.62%	27.97%	39.69%
ROA Full definition →	13.78%	12.54%	14.48%	17.46%
ROIC Full definition →	42.61%	51.10%	43.78%	39.95%
Return on Tangible Assets Full definition →	28.02%	29.50%	38.12%	60.46%
Average Days of Receivables Full definition →	53.76	42.30	85.75	57.79
Free Cash Flow per Share Full definition →	0.81	1.05	0.83	0.85
Free Cash Flow Full definition →	41.15	53.61	41.73	42.87
Capital Expenditures Full definition →	—	—	(0.07)	(0.12)
Other line items
Cash ROIC Full definition →	17.70%	22.03%	16.53%	17.46%
Accounts Receivable Turnover Full definition →	7.71	8.82	5.33	4.81
Accounts Payable Turnover Full definition →	13.65	8.18	11.01	7.05
Inventory Turnover Full definition →	5.31	6.65	8.17	8.06
Average Days of Payables Full definition →	19.47	51.37	31.73	47.62
Days of Inventory on Hand Full definition →	83.56	54.68	34.61	70.66
Tax Rate Full definition →	(0.14)	(0.16)	(0.13)	0.20
Research and Development Expense of Revenue Full definition →	30.90%	29.93%	27.18%	28.49%
Selling, General and Administrative Expense of Revenue Full definition →	30.78%	31.55%	31.02%	32.59%
Share Based Compensation of Revenue Full definition →	3.09%	3.00%	3.04%	3.34%
Interest Coverage Full definition →	8.65	5.70	5.63	4.13
Operating CF/Net income Full definition →	1.54	2.20	1.34	1.16
Depreciation/Fixed assets Full definition →	101.74	86.50	58.49	36.47
Capex/Depreciation Full definition →	0.00	0.00	(0.01)	(0.01)
Revenue per Share Full definition →	4.54	4.47	4.57	4.21
Operating CF per Share Full definition →	0.81	1.05	0.84	0.85
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly